Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity.
Abstract
Address
Biotigr Lab
Team 4 UMR-S 1134 INSERM
Université de Paris
Hôpital NECKER – Enfants Malades
149 rue de Sèvres
75015 Paris, France